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Tendency to mimic others’ emotional facial expressions predicts empathy and may represent a physiological
marker of psychopathy. Anatomical connectivity between amygdala, cingulate motor cortex (M3, M4), and facial
nucleus demonstrates a potential neuroanatomical substrate for mimicry, though pharmacological influences are
largely unknown. Norepinephrine modulation selectively impairs negative emotion recognition, reflecting a
potential role in processing empathy-eliciting facial expressions. We examined effects of single doses of
propranolol (beta-adrenoceptor blocker) and reboxetine (selective norepinephrine reuptake inhibitor) on auto-
matic facial mimicry of sadness, anger, and happiness, and the relationship between mimicry and empathy. Forty-
five healthy volunteers were randomized to 40 mg propranolol or 4 mg reboxetine. Two hours after drug subjects
viewed and rated facial expressions of sadness, anger, and happiness, while corrugator, zygomatic, and mentalis
EMG were recorded. Trait emotional empathy was measured using the Balanced Emotional Empathy Scale. EMG
confirmed emotion-specific mimicry and the relationship between corrugator mimicry and empathy. Norepine-
phrine modulation did not alter mimicry to any expression or influence the relationship between mimicry and
empathy. Corrugator but not zygomaticus mimicry predicts trait empathy, consistent with greater anatomical
connectivity between amygdala and M3 coding upper facial muscle representations. Although influencing emo-
tion perception, norepinephrine does not influence emotional facial mimicry or its relationship with trait empathy.
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INTRODUCTION
Human social interactions are critically dependent on
emotional communication and, in particular, emotional
signals portrayed in the face (Darwin, 1872). The
primacy of facial expressions to social interaction is
demonstrated by primate studies which show cross-
cultural (Izard 1971) and cross-species (Burrows,
Waller, Parr, & Bonar, 2006) consistency of facial mus-
cle configurations for specific emotional expressions,
suggesting an evolutionarily conserved neuroanatomical
basis. Spontaneous mimicry of observed emotional
facial expressions by human newborns extends this
position and suggests “hard-wired” connections
between facial emotion perception and emotional
expression (Field, Woodson, Greenberg, & Cohen,
1982).
Tract tracing studies that show connectivity
between lateral-basal amygdala nucleus, cingulate
motor cortex (M3, M4) and brainstem facial motor
nucleus suggest a potential anatomical basis for this
mimicry (Morecraft et al. 2007; Morecraft, Lousie,
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Herrick, & Stilwell-Morecraft, 2001). For example,
the lateral-basal amygdala nucleus, which together
with the lateral amygdala nucleus is believed to play a
key role in extracting emotionally salient sensory
information across modalities (LeDoux, 2000), shows
dense bidirectional connectivity to the rostral cingulate
motor cortex (M3) which codes a representation
predominantly of the upper face. Less dense projec-
tions from lateral-basal amygdala also occur to more
caudal M4, which itself codes a representation
predominantly of the lower face. Both M3 and M4
show projections to the facial motor nucleus in the
brainstem, potentially providing a two- or three-
synapse bidirectional anatomical framework for emo-
tional facial mimicry.
Consistent with a pivotal role in healthy human
social interaction, emotional facial communication is
impaired across the breadth of human psychopathology.
For example, in depression, depressed individuals have
a tendency to misclassify neutral or ambiguous emo-
tional facial expressions as negative (Rubinow & Post,
1992). This effect correlates with increased amygdala
activity and is reversed after treatment with antidepres-
sant medication (Sheline et al., 2001). Antidepressants
such as the selective norepinephrine reuptake inhibitor
Reboxetine also induce a positive emotional perceptual
bias in healthy subjects (Harmer, Shelley, Cowen, &
Goodwin, 2004; Norbury, Mackay, Cowen, Goodwin, &
Harmer, 2008), suggesting that norepinephrine posi-
tively colors the emotional perception of facial expres-
sions in humans. Recognition that norepinephrine
regulates neuronal excitability in the basolateral amy-
gdala by facilitation of GABA (Roniadou-Anderjaska,
Qashu, & Braga, 2007) release demonstrates a potential
neuroanatomical locus for this effect.
Although the majority of studies investigating the
role of emotional facial expressions in human social
communication have focused on mechanisms of emo-
tion perception, theoretical considerations suggest
similar importance for mechanisms of emotional
expression. Lipps (1907) first proposed that observa-
tion of emotional displays leads to mimicry and, via a
feedback process, a convergence of observed and
observer’s emotional feeling states. This tendency to
automatically mimic and synchronize expressions,
postures, and vocalizations with another person and
consequently converge emotionally has subsequently
been termed “emotional contagion” (Hatfield,
Cacioppo, & Rapson, 1994) and argued to form the
basis for emotional empathy (de Wied, van Boxtel,
Zaalberg, Goudena, & Matthys, 2006).
Supporting this position, healthy individuals observ-
ing emotional expressions automatically produce con-
gruent facial responses (Dimberg & Karlsson, 1997)
even when unaware of the emotion displayed
(Dimberg, Thunberg, & Elmehed, 2000). Strikingly,
individuals high in trait empathy show the greatest
mimicry of others’ emotional expressions (Sonnby-
Borgstrom 2002; Sonnby-Borgstrom, Jonsson, &
Svensson, 2003) and further, report a greater change
in their own emotional state when their facial expres-
sions are surreptitiously modulated (Andreasson &
Dimberg, 2008). These findings suggest that more
empathetic individuals show a greater sensitivity to
others’ emotional facial displays, expressed as an
increase in mimicry and likely in experienced congru-
ent emotion (Andreasson & Dimberg 2008). Whether
this results from enhanced emotion perception (Harrison,
Wilson, & Critchley, 2007), coupling of perception to
facial responses (Sonnby-Borgstrom, 2002), feedback
from motor responses, or interaction between these
factors is currently unclear.
In addition to an effect on emotion perception,
depression also biases emotional expression, in par-
ticular responses in the upper face. Depressed individ-
uals display less spontaneous happy facial
expressions and less mimicry of observed happiness
indexed not by a reduction in zygomaticus major
(ZM) smiling responses but by greater corrugator
supercilli (CS) frowning activity (Schwartz et al.,
1978; Schwartz, Fair, Salt, Mandel, & Klerman,
1976). Emotional facial mimicry indexed by CS
responses is also impaired in autism (Hermans, van
Wingen, Bos, Putman, & van Honk, 2009), opposi-
tional defiant disorder (ODD) and conduct disorder
(CD) (de Wied et al., 2006), conditions characterized
by poor empathetic skills and poor ability to under-
stand and share another’s emotional state (Cohen &
Strayer, 1996). Together these findings highlight
contributions of perception and reciprocation of emo-
tional facial expressions, in particular upper facial
features, to adaptive human social interaction.
Anatomical studies suggest the amygdala is a critical
substrate mediating the perception and, through con-
nectivity to M3 and to a lesser extent M4, expression
and mimicry of emotional facial expressions. Pharma-
cological influences on perceptual biases are well
described, but their role in expressive components is
currently unclear.
We addressed this issue by investigating the effect
of norepinephrine modulation on implicit mimicry of
both upper and lower facial muscles and the relation-
ship between facial mimicry and emotional empathy.
In a double-blind study, healthy volunteers received
either reboxetine, a selective norepinephrine reuptake
inhibitor, or propranolol, a centrally acting beta-adrener-
gic antagonist, before observing randomized positive
(happy) and negatively (sad and angry) valenced facialA ROLE FOR NOREPINEPHRINE? 395
expressions. Each expression was rated for subjective
arousal/intensity and valence. Mimetic upper (CS)
and lower (ZM) facial responses were simultaneously
recorded using electromyography (EMG). We pre-
dicted that if norepinephine selectively modulates
emotional expression pathways, this would be
expressed in differential mimetic responses between
groups and as differential relationships between facial
mimicry and emotional empathy scores.
METHODS
Subjects and pharmacological 
manipulation
Forty-five participants were recruited from a web-
based volunteer recruitment site at University
College London. Five participants were excluded
from the analysis because of technical problems,
leaving 40 subjects (14 female), median 24 years
(range 18–34). Twenty-one subjects received rebox-
etine and 19 propranolol. Participants were screened
by clinical interview to exclude those with a history
of asthma, psychiatric or significant medical illness,
or current medication use. All participants also
underwent a 12-lead electrocardiograph (ECG)
which was reviewed by a registered doctor (NAH) to
exclude participants with evidence of cardiac con-
duction abnormalities. All participants gave their
written consent to participate in this study, which
was approved by the joint National Hospital for
Neurology and Institute of Neurology research eth-
ics committee.
Volunteers were randomly allocated to receive
either reboxetine 4 mg, a selective norepinephrine
reuptake inhibitor, or propranolol 40 mg, a centrally
acting nonselective B1 and B2 adrenergic receptor
blocker. Both experimenter (RM) and subject were
blind to drug administration. A further experimenter
(NAH) was aware of drug administration to ensure
participant safety but played no role in direct data
acquisition. Timing of the behavioral task was
informed by the pharmacokinetics of reboxetine and
propranolol, which show peak plasma levels at 1.5–2 h
after oral drug administration.
Stimuli and testing procedure
Participants were individually tested 2 h after drug
administration in a dark, electrically isolated room,
with stimuli displayed in a 400 × 400 pixel array on
a 21-inch Sony GDM-F520 CRT. Images of facial
expressions were taken from the Karolinska Directed
Emotional Faces (KDEF) series (Lundqvist, Flykt, &
Öhmann, 1998). Eight male and eight female facial
identities were used, each displaying one of three
emotional expressions (happy, sad, and angry). Each
identity expression combination was shown three
times.
To ensure that participants attended to the face
stimuli and to minimize startle responses, we
preceded each trial with a 2000 ms duration scram-
bled image of equal luminance to the ensuing emo-
tional facial expression. A visual analog scale (VAS)
represented by a 200 mm horizontal line was pre-
sented below the image 1500 ms after face presenta-
tion. Subjects successively rated the valence (−10 to
+10), intensity/arousal (0 to +10), and attractiveness
(0 to +10) of each emotional face using a mouse-con-
trolled cursor. Each facial expression was displayed
until all face ratings were completed.
EMG reactions
Facial EMG activity was measured using miniature
bipolar Ag/AgCl electrodes coated with high-
conductance gel placed according to guidelines for
EMG research (Fridlund & Cacioppo, 1986) on the
left side of the face. The subjects’ skin was cleansed and
lightly abraded with disposable pads (70% alcohol and
pumice) before the electrodes were applied. Inter-
electrode distance was approximately 1.5 cm. Activity of
the CS (FACS AU 4), which shows an increase in activity
in anger and sadness and a decrease in happiness, was
employed to assess activity in the upper face. ZM
(FACS AU 12), which shows the opposite pattern of
activity, was employed to assess responses in the lower
face. We also recorded mentalis (ME: FACS AU 17), a
lower facial muscle, to attempt to differentiate responses
to sadness and anger. However, due to technical
difficulties associated with recording from this small
muscle in the majority of subjects, these data were not
further analyzed. EMG signals were recorded at a sam-
pling rate of 1 kHz using a CED 1902 preamplifier and
CED Power 1401 data acquisition interface and stored
on a laptop computer running Spike2 software.
To conceal recording of facial muscle activity we
adopted the established strategy of informing partic-
ipants that their sweat gland activity was being meas-
ured (Sonnby-Borgstrom, Jonsson, & Svensson, 2003).
At post-testing debriefing no participant realized the
true purpose of the electrodes, implying that they
were not aware that their facial muscle activity was
of interest until the true purpose of the study was
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EMG data were analyzed in Matlab using pur-
pose-written routines. Data were first filtered using
a sixth-order Butterworth filter (bandwidth 10–480
Hz), then rectified and smoothed using the root
mean squared (rms) technique with a time constant
of 200 ms. Following Dimberg (1982), facial EMG
responses in the 500 ms period 500–1000 ms after
stimulus onset were determined and expressed as
the change in activity from a 1000 ms pre-stimulus
baseline. Individual EMG responses were Z-nor-
malized within muscle sites and participants to
reduce participant and site-specific variability
(Bush, Hess, & Wolford, 1993). These were then
used to produce participant-specific mean, normal-
ized responses to each emotional expression in
each facial muscle.
Questionnaires
Participants completed the Mehrabian Balanced
Emotional Empathy Scale (BEES) (Mehrabian &
Epstein, 1972) after exposure to the facial expres-
sions. The BEES is a widely used and validated meas-
ure of emotional empathy with a high internal
consistency (Cronbach alpha = 0.87), suggesting that
it measures a single, unidimensional latent construct
(Mehrabian, 1997). Beck’s Depression Inventory
revised (BDI-I) (Beck, Steer, Ball, & Ranieri, 1996)
and the Toronto Alexithymia Scale (TAS-20) (Bagby,
Taylor, & Parker, 1994) were also completed. Ques-
tionnaires were completed after the emotional facial
processing task to minimize the risk of behavior in the
experiment being influenced by the content of the
questionnaires.
Statistical analysis
All statistical analyses were performed in SPSS
v.16.0 (SPSS, Inc). Effects of observed emotional
expression, noradrenergic manipulation and empathy
scores on mean subjective ratings of emotional inten-
sity/arousal and valence were analyzed in separate
mixed measures ANOVAs.
Effects of observed emotional expression and
noradrenergic modulation on muscle-specific EMG
responses were determined using a 3 (expression) ×
2 (drug) × 2 (muscle) mixed-measures ANOVA.
Interaction of each of these factors with emotional
empathy was determined by repeating this analysis
with the addition of empathy score (BEES) as a
continuous between-subjects factor. Inhomogeneity
of variance was controlled as appropriate by reducing
the degrees of freedom using the Greenhouse-Geisser
correction.
RESULTS
Questionnaires
All subjects bar one scored in the minimal severity
range (1–13) on the BDI. One subject in the Reboxet-
ine group scored in the mild severity range (14–19)
without meeting criteria for ICD-10 depressive epi-
sode. All subjects scored below the recommended
threshold for alexithymia (Taylor et al., 1988) of 74 on
the TAS. Subject demographics are given in Table 1.
Subjective ratings of emotional facial 
expressions
There was a significant main effect of observed
emotion on both intensity/arousal and valence rat-
ings, F(2) = 33.75, p < .001; F(2) = 20.54, p < .001,
respectively, with significant differences (p < .002)
between all pairs of contrasts (angry > happy > sad)
for intensity/arousal and (happy > angry > sad) for
valence. Noradrenergic modulation had no signific-
ant effect on either rating, F(1) = 0.41, p > .1; F(1)
= 0.39, p > .1, and there were no significant interac-
tions between drug and ratings, F(2) = 0.47, p > .1;
F(2) = 1.1, p > .1. There was also no significant
main effect of emotional empathy on overall emo-
tion rating scores. Interestingly, however, we did
observe a significant empathy × expression interac-
tion on arousal ratings, F(2) = 4.13, p < .02, driven
by a tighter correlation between empathy and
arousal to sadness than happy or angry expressions,
F(1) = 4.45, p < .04; F(1) = 10.13, p < .003. Analy-
sis of this interaction showed that more empathetic
individuals rated the sad facial expressions as more
arousing than low-empathy participants.
TABLE 1 
Demographics of participants
Age BEES TAS BDI
Propranolol 24.9 (3.8) 31.8 (33.2) 54.6 (6.4) 4.1 (4.2)
Reboxetine 25.8 (4.8) 34.4 (20.5) 54.3 (7.2) 5.2 (4.6)
T score 0.65 0.30 0.14 0.79
P value .52 .76 .89 .44
Notes: BEES, Balanced Emotional Empathy Scale score; TAS,
Toronto Alexithymia Scale; BDI, Beck’s Depression Inventory.
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EMG responses to observation of 
emotional facial expressions
Time course of EMG activity in CS and ZM mus-
cles to each observed emotional facial expression is
shown in Figure 1. There was no significant main
effect of facial muscle, F(1) = 3.57, p = ns, or nore-
pinephric manipulation, F(1) = 0.10, p = ns, on
EMG responses, although similarly to our analysis of
arousal and valence ratings we did observe a signific-
ant main effect of emotional expression, F(2) = 3.41,
p < .04.
Importantly, there was also a significant emotion ×
muscle interaction, F(2) = 8.02, p < .002, demonstrat-
ing mimicry of observed emotional expression
(Figure 2). Post-hoc contrasts showed significantly
greater CS response to both sad, F(1) = 9.81, p < .003,
and angry, F(1) = 7.31, p < .01, than happy expres-
sions. Conversely, ZM responses were significantly
greater to observation of happy than angry or sad
expressions, F(1) = 4.81, p < .03. There was no signi-
ficant interaction between responses to sad and angry
expressions for either muscle.
Norepinephric modulation again showed no inter-
action with muscle-specific EMG responses across
emotions or overall EMG responses to individual
emotions. There was no significant three-way interac-
tion between norepinephric modulation, observed
facial expression, and observers’ own facial muscular
response. This finding confirms firstly that norepine-
phric modulation does not result in a general change
in facial motor responses to observed emotional
expressions. More importantly, it also demonstrates
that norepinephric modulation does not have a differ-
ential emotion-specific influence on mimetic
responses to observed sadness, anger, or happiness.
This implies that previously reported effects of pro-
pranolol on speeded motor responses to expressions
of sadness do not extend to facial motor responses. To
further explore the robustness of this result, we also
investigated individual post-hoc contrasts. Again
these analyses confirmed that norepinephric modula-
tion had no significant effect on any emotion-specific
EMG response described above (p > .05 for all post-
hoc analyses).
Correlation of EMG responses 
with BEES
Previous studies have reported a differential CS and ZM
mimetic response to happy and angry faces in high- and
low-empathy subjects, with high-empathy subjects
showing a greater mimetic response at least in brief
exposures (Sonnby-Borgstrom, 2002; Sonnby-Borgstrom
et al., 2003). We explored this effect in our current data
by including BEES as a between-subjects factor in our
previous 3 (emotion) × 2 (muscle) × 2 (norepinephric
manipulation) ANOVA. Inclusion of BEES in this
model identified a significant emotion × BEES
Figure 1. Mean corrugator (upper) and zygomaticus (lower)
responses to observation of happy, sad, and angry facial expres-
sions. The area in gray denotes the period of EMG responses used
in all subsequent analyses.
Figure 2. Mean normalized EMG responses (± SE) in CS and
ZM muscles to observation of happy, sad, and angry facial expres-
sions (500–1000 ms after stimulus onset).398 HARRISON, MORGAN, CRITCHLEY
interaction, F(2) = 16.87, p < .0001, and muscle × emo-
tion × BEES interaction, F(2) = 6.15, p < .003. Post-hoc
regression analyses of these interactions revealed that
they were driven by differential correlations between
BEES and CS activity to happy, sad, and angry facial
expressions: in particular, differences in correlations
between BEES and happy and sad, F(1) = 6.70, p < .02,
and happy and angry, F(1) = 8.76, p < .005, facial
expressions (Figure 3). There were no significant corre-
lations between ZM responses to any emotional expres-
sion and BEES.
Finally, to determine the relative contributions of
arousal ratings and EMG responses to emotional
empathy scores, we performed a multiple regression
analysis including all factors significantly predicting
BEES score in the above analyses (arousal ratings of
sad expressions and CS responses to happy, sad, and
angry expressions). A backwards removal method
was adopted (consistent with the exploratory nature of
this analysis). Mimetic CS responses to observed
angry expressions, t(1) = 4.56, p < .0001, and arousal
ratings of sad expressions, t(1) = 3.38, p < .002, explained
over 40% of the variance in individuals’ emotional empa-
thy score, F(2) = 14.4, p < .00003, adjusted R2 = .41. To
confirm our reported lack of effect of noradrenergic
modulation on mimetic responses, we also repeated
this regression analysis as a general linear model
incorporating norepinephric modulation as a random
between-subjects factor. Again, this analysis con-
firmed (1) correlation between CS mimicry to anger
and empathy score and (2) correlation between
arousal ratings of sad expressions and empathy score.
There were no significant interactions between any
mimetic response and norepinephric modulation (p > .1
all interactions).
DISCUSSION
Despite the proposed central role of facial mimicry to
emotion contagion and emotional empathy, relatively
few studies have investigated the mechanisms mediat-
ing this relationship (Hess, Philippot, & Blairy, 1999).
To our knowledge this is the first study to investigate
the effects of norepinephrine on spontaneous facial
mimicry and its relationship with trait emotional
empathy. Our study provides several new findings.
Firstly we replicated the emotional facial imitation
phenomenon in 40 healthy subjects treated with pro-
pranolol or reboxetine, with differential modulation of
CS and ZM to observed happy vs. sad and angry
facial expressions. These data build on previous
observations of facial mimicry to static (Dimberg,
1982; Dimberg & Lundquist, 1988) and dynamic emo-
tional facial expressions (Achaibou, Pourtois,
Schwartz, & Vuilleumier, 2008). Onset of the mimetic
response 300–500 ms after stimulus presentation
supports the automatic nature of the mimetic response
we observed. This is also substantiated by the fact that
none of the subjects was aware of the true nature of the
study. Similarly to Achaibou et al., we used a large
number of stimuli indicating that facial mimicry can be
elicited over many successive trials, a finding that
again supports the automaticity of the mimetic
response.
Our data also provide the first independent replica-
tion of Sonnby-Borgstrom’s report of a relationship
between intensity of facial mimicry and trait emo-
tional empathy (Sonnby-Borgstrom, 2002; Sonnby-
Borgstrom et al., 2003). Using a multiple regression
analysis we extend this finding to show a specific
relationship between upper (CS) but not lower (ZM)
facial mimicry and trait emotional empathy. Interest-
ingly, these findings also applied to expressions of
happiness where a reduction of CS activity was a
stronger predictor of empathy than increase in ZM
activity. Effects of depression on facial expressions of
experienced emotion (Schwartz et al., 1976) and
mimicry of observed emotions (Schwartz et al., 1978)
have also previously reported a selective effect on
upper rather than lower facial features. Similarly,
individuals with disorders of social communication
such as Asperger’s syndrome (Hermans et al., 2009)
and conduct disorder (de Wied et al., 2006) have been
reported to show a selective impairment in mimetic
responses in the upper face.
Explanation for these findings may rest on the
anatomy of facial mimicry. Emotion perception
across modalities activates lateral and basal amygdala
nuclei (LeDoux, 2000), the latter of which shows
strong bidirectional connectivity with cingulate motor
Figure 3. Correlation between EMG responses in CS and ZM
muscles to observation of happy, sad, and angry facial expressions
and BEES. Mean beta (± SE) displayed.A ROLE FOR NOREPINEPHRINE? 399
cortices representing upper facial features (M3) but
only weak connectivity with areas representing the
lower face (M4). Basolateral amygdala, however, also
shows strong connectivity to the central amygdala
nucleus and from there to the hypothalamus, cingu-
late, insula, and other regions mediating physiologi-
cal, behavioral, and subjective emotional responses. It
is therefore interesting to speculate that mimetic
responses in the upper face may perhaps provide a
more direct representation of efferent amygdala
responses to emotional stimuli. Alternately, following
the logic of the facial feedback hypothesis, feedback
to the amygdala from upper facial features may play a
more prominent role in mediating subjective emo-
tional responses.
Interestingly, the empathy scale employed in our
study, the BEES, is a refinement of the earlier QMEE
scale (Mehrabian & Epstein, 1972) used by Sonnby-
Borgstrom et al. to show a relationship with emotional
empathy. In this regard, previous investigators using
other measures of empathy such as the emotional quo-
tient (EQ) have failed to show a relationship with
mimicry (Achaibou et al., 2008). It has been argued
that this may be because the QMEE is a broad meas-
ure of emotional empathy sensitive to general emo-
tional arousability (Chlopan, McCain, Carbonell, &
Hagen, 1985). This raises the issue of the range of
elicitors of emotionally congruent facial responses.
De Gelder and colleagues have demonstrated emo-
tionally congruent facial EMG responses to emotional
bodily postures, which occur even when the stimuli
are presented outside of the subjects’ awareness
(Tamietto and de Gelder 2009). These data suggests a
more general linkage between emotion perception and
congruent facial responses and raise the question of
whether highly empathetic individuals on the BEES
would also show strong congruent facial responses to
emotional stimuli across sensory modalities.
Finally, we show that norepinephric modulation, in
contrast to its effects on emotion perception, does not
modulate emotional mimicry or its relationship with
emotional empathy. It should be noted, however, that
this conclusion is drawn by comparing effects of
reboxetine vs. propranolol without an additional pla-
cebo arm. Though propranolol has known b1 and b2
blocking activity (compared to the norepinephrine
increasing effects of reboxetine), its pharmacology is
complex. For example, some studies have shown that
propranolol increases synaptic norepinephrine (Tack-
ett, Webb, & Privitera, 1981), suggesting that it may
additionally have indirect a1 agonist activity. Future
studies should also consider the addition of a placebo
arm to investigate this potential effect. Our finding of
an absence of an effect of norepinephine modulation
on emotional mimicry should be interpreted in the
context of emotion perception studies, many of which
have shown an effect of norepinephrine only on
weakly arousing negatively valenced emotional stim-
uli, with negligible effect on more potent stimuli
(Harmer, Perrett, Cowen, & Goodwin, 2001). These
findings suggest a potential sensory threshold effect,
whereby norepinephrine modulates the limit above
which perceived stimuli are labeled as negatively
valenced. To minimize potential sensory threshold
effects we therefore utilized only highly arousing
facial stimuli in the current study. Consistent with the
potential sensory threshold effect of norepinephrine,
there were no significant differences in arousal or
valence ratings for positive or negatively valenced
stimuli between groups in our current study.
In contrast to our current findings, Hermans et al.
showed that acute administration of testosterone to
healthy females was associated with a significant
reduction in differential corrugator responses to happy
compared to angry facial expressions (Hermans,
Putman, & van Honk, 2006) (a trend-level effect in the
same direction was also found in ZM responses). They
argued that the influence of testosterone on mimetic
responses underpinned the effects of high testosterone
on empathy.
In conclusion, we have shown that differential CS
but not ZM responses to emotional facial stimuli
predict emotional empathy. Despite influencing nega-
tive emotion perception, acute norepinephrine modu-
lation does not modulate facial mimetic responses.
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